2018
DOI: 10.1007/s11356-018-1840-6
|View full text |Cite|
|
Sign up to set email alerts
|

Genetic aberrations of the K-ras proto-oncogene in bladder cancer in relation to pesticide exposure

Abstract: In Egypt, bladder cancer is one of the most popular cancers, accounting for 31% of all cancer cases. It ranks first in males about 16.2% of male cancer. The incidence in rural areas among males is near 32 per 100,000. The exact etiology of bladder cancer is still unknown; K-ras gene is known as a critical DNA target for chemical carcinogens such as pesticide. Some occupational hazard exposure is thought to be directly genotoxic, while others might enhance the mutagenicity and carcinogenicity of directly acting… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 36 publications
0
7
0
Order By: Relevance
“…It is important to note that pesticides have also been implicated in bladder tumorigenesis ( 347 , 348 ) through oxidative stress and KRAS mutation in Egyptian occupationally-exposed individuals ( 347 ).…”
Section: Resultsmentioning
confidence: 99%
“…It is important to note that pesticides have also been implicated in bladder tumorigenesis ( 347 , 348 ) through oxidative stress and KRAS mutation in Egyptian occupationally-exposed individuals ( 347 ).…”
Section: Resultsmentioning
confidence: 99%
“…With regard to BCL2, it has been widely demonstrated that the exposure to pesticides can cause breaks and translocations of this gene, mainly represented by the t(14;18) translocation, predisposing the development of lymphomas [37]. In the same manner, pesticide exposure can induce different genetic damages, affecting the KRAS gene associated with an increased risk of bladder cancer [54].…”
Section: Discussionmentioning
confidence: 99%
“…Since DNA methylation represents a molecular mechanism related to gene inhibition, it is believed that methylation in cancer may promote tumor phenotype by inhibiting genes that are initially active in the source tissues, especially those related to tumor suppressor factors, such as Rb, P53 etc [23,24]. On the other hand, the other hypomethylation sites are potentially associated with oncogene-directed methylation-associated gene-repression pathways, taking Myc, Ras and Src as examples [25][26][27]. A study by Irizarry etc show that most methylation alterations in colorectal cancer occur in 'CpG island shores', with hypermethylation enriched closer to the associated CpG islands [28].…”
Section: Discussionmentioning
confidence: 99%